Skip to Content

Mirtazapine Tablets

Last Updated: September 22, 2014
Status: Resolved

Products Affected - Description

Mirtazapine tablets, Greenstone
15 mg, 30 count (NDC 59762-1416-03) - discontinued
15 mg, 60 count (NDC 59762-1416-06) - discontinued
15 mg, 90 count (NDC 59762-1416-09) - discontinued
15 mg, 500 count (NDC 59762-1416-05) - discontinued
30 mg, 30 count (NDC 59762-1417-03) - discontinued
30 mg, 60 count (NDC 59762-1417-06) - discontinued
30 mg, 90 count (NDC 59762-1417-09) - discontinued
30 mg, 500 count (NDC 59762-1417-05) - discontinued
45 mg, 30 count (NDC 59762-1418-03) - discontinued
45 mg, 60 count (NDC 59762-1418-06) - discontinued
45 mg, 90 count (NDC 59762-1418-09) - discontinued
45 mg, 500 count (NDC 59762-1418-05) - discontinued

Mirtazapine oral disintegrating tablets, Greenstone
15 mg, 30 count, unit dose (NDC 59762-1410-07) - discontinued
30 mg, 30 count, unit dose (NDC 59762-1412-07) - discontinued
45 mg, 30 count, unit dose (NDC 59762-1414-07) - discontinued 

 
Mirtazapine tablets, Sandoz
15 mg, 30 count (NDC 00185-0020-30) - discontinued
15 mg, 1000 count (NDC 00185-0020-10) - discontinued
30 mg, 30 count (NDC 00185-0212-30) - discontinued
30 mg, 1000 count (NDC 00185-0212-10) - discontinued
45 mg, 30 count (NDC 00185-0222-30) - discontinued
45 mg, 1000 count (NDC 00185-0222-10) - discontinued

Reason for the Shortage

  • Actavis discontinued their mirtazapine 15 mg oral disintegrating tablets in May 2014.
  • Greenstone discontinued all remaining mirtazapine presentations in December 2013.
  • Sandoz discontinued their mirtazapine presentations in early-2014.
  • Teva discontinued various unit dose presentations throughout 2013, including mirtazapine. Teva could not provide a reason for the shortage. 

Available Products

Mirtazapine tablets, Actavis (Watson)
15 mg, 30 count (NDC 00591-1117-30)
15 mg, 1000 count (NDC 00591-1117-10)
30 mg, 30 count (NDC 00591-1118-30)
30 mg, 1000 count (NDC 00591-1118-10)
45 mg, 30 count (NDC 00591-1119-30)

Mirtazapine oral disintegrating tablets, Actavis (Watson)
15 mg, 30 count, unit dose (NDC 00591-2230-15) - discontinued

30 mg, 30 count, unit dose (NDC 00591-2470-15)
 
Mirtazapine tablets, Apotex
15 mg, 30 count (NDC 60505-0247-01)
15 mg, 1000 count (NDC 60505-0247-08)
30 mg, 30 count (NDC 60505-0248-01)
30 mg, 1000 count (NDC 60505-0248-08)
45 mg, 30 count (NDC 60505-0249-01)
45 mg, 1000 count (NDC 60505-0249-08)

Mirtazapine tablets, Aurobindo
7.5 mg, 30 count (NDC 13107-0001-30)
7.5 mg, 500 count (NDC 13107-0001-05)
15 mg, 30 count (NDC 13107-0031-34)
30 mg, 30 count (NDC 13107-0003-34)
30 mg, 500 count (NDC 13107-0003-05)
45 mg, 30 count (NDC 13107-0032-34)
45 mg, 500 count (NDC 13107-0032-05)
 
Mirtazapine tablets, Mylan
15 mg, 30 count (NDC 00378-3515-93)
15 mg, 1000 count (NDC 00378-3515-10)
30 mg, 30 count (NDC 00378-3530-93)
30 mg, 500 count (NDC 00378-3530-05)
45 mg, 30 count (NDC 00378-3545-93)
45 mg, 500 count (NDC 00378-3545-05)
 
Mirtazapine tablets, Teva
15 mg, 30 count (NDC 00093-7206-56) 
30 mg, 30 count (NDC 00093-7207-56)
45 mg, 30 count (NDC 00093-7208-56)
 
Mirtazapine oral disintegrating tablets, Teva
15mg, 30 count, unit dose (NDC 00093-7303-65)
30 mg, 30 count, unit dose (NDC 00093-7304-65)
45 mg, 30 count, unit dose (NDC 00093-7305-65)
 
Mirtazapine tablets, Mylan Institutional
15 mg, 100 count, unit dose (NDC 51079-0086-20)
15 mg, 300 count, unit dose (NDC 51079-0086-56)
30 mg, 100 count, unit dose (NDC 51079-0087-20)
30 mg, 300 count, unit dose (NDC 51079-0087-56)
45 mg, 300 count, unit dose (NDC 51079-0088-56)
45 mg, 100 count, unit dose (NDC 51079-0088-20)

Remeron tablets, Merck
15 mg, 30 count (NDC 00052-0105-30)
30 mg, 30 count (NDC 00052-0107-30)
45 mg, 30 count (NDC 00052-0109-30)

Remeron oral disintegrating tablets, Merck
15 mg, 30 count, unit dose (NDC 00052-0106-30)
30 mg, 30 count, unit dose (NDC 00052-0108-30)
45 mg, 30 count, unit dose (NDC 00052-0110-30)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

September 22, 2014; July 18, 2014; June 19, 2014; June 5, 2014; May 22, 2014; April 24, 2014; April 10, 2014; February 27, 2014; January 17, 2014; January 16, 2014; December 20, 2013; November 25, 2013; November 15, 2013; October 31, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide